Impact of Adeno‐Associated Virus Production on Capsid Heterogeneity and Product Quality
Biotechnology and Bioengineering · 2026
DOI: 10.1002/bit.70219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2026. Verfasst von Alex Meola und 20 weiteren Autor:innen. Beteiligte Einrichtung: Oxford Biomedica (US) LLC, Bedford, Massachusetts, USA. Hauptthemen laut MEDLINE: Dependovirus, Capsid, Capsid Proteins. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Oxford Biomedica (US) LLC.
Abstract (Originalsprache)
Adeno‐associated virus (AAV) capsids are inherently heterogeneous, arising from viral protein stoichiometric assembly, post‐translational modifications, genome packaging, and manufacturing process conditions. Understanding how AAV manufacturing processes affect capsid heterogeneity and corresponding drug product quality impact is essential for AAV‐based gene therapies. We investigated the effects of extended production duration and capsid localization at harvest on capsid heterogeneity. Analytical characterization revealed that prolonged production increased extracellular AAV concentrations but also elevated the proportion of empty capsids, overall hydrophobicity, and deamidation of viral protein (VP). These changes altered charge‐dependent separation during anion exchange chromatography (AEX). Capsids derived from intracellular fractions showed even higher levels of deamidation and empty particles compared to extracellular populations, further impacting AEX purification performance. Collectively, these findings demonstrate that both production time and capsid localization significantly influence AAV purification process performance and critical quality attributes. Process control strategies to minimize capsid heterogeneity are consequently critical to ensure a consistent quality profile in AAV manufacturing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oxford Biomedica (US) LLC, Bedford, Massachusetts, USA.
ORCID-Profile: Xiaotong Fu
Förderung
- Oxford Biomedica (US) LLC
Zitieren
APA
Meola, A., Fu, X., Laughlin, S., Thiers, T., Mustich, L., Wiberg, E., Kim, Y., Zhang, Q., Fandunyan, E., Jaiswal, R., Perez, M., Rogers, B., DaSilva, E., Rouleau, D., Lushi, R., Horton, R., Brazell, B., Mercaldi, M., Yin, J., …, & Iwuchukwu, I. (2026). Impact of Adeno‐Associated Virus Production on Capsid Heterogeneity and Product Quality. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70219
Vancouver
Meola A, Fu X, Laughlin S, Thiers T, Mustich L, Wiberg E, et al. Impact of Adeno‐Associated Virus Production on Capsid Heterogeneity and Product Quality. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70219
BibTeX
@article{Meola2026,
author = {Meola, Alex and Fu, Xiaotong and Laughlin, Sarah and Thiers, Thomas and Mustich, Luke and Wiberg, Eli and Kim, Yongseok and Zhang, Qi and Fandunyan, Eugenia and Jaiswal, Richa and Perez, Matt and Rogers, Ben and DaSilva, Evan and Rouleau, David and Lushi, Rudenc and Horton, Rob and Brazell, Brian and Mercaldi, Michael and Yin, Jin and McGivney, James and Iwuchukwu, Ify},
title = {Impact of Adeno‐Associated Virus Production on Capsid Heterogeneity and Product Quality},
journal = {Biotechnology and Bioengineering},
year = {2026},
doi = {10.1002/bit.70219}
}
EUVIMED